Filipa Martins Alves | Health Sciences | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

Filipa Martins Alves · Health Sciences · Portugal

Filipa Martins Alves
Affiliation Unidade Local de Saúde Alto Ave
Country Portugal
Subject area Health Sciences
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-2813-6556

Filipa Martins Alves is identified in the supplied information as being affiliated with Unidade Local de Saúde Alto Ave in Portugal. The subject area associated with this academic recognition profile is Health Sciences. The profile is prepared in the context of the International Research Hypothesis Excellence Award and provides an overview of the stated affiliation, research domain, and researcher identification details. The supplied ORCID identifier provides a persistent reference for locating the researcher’s academic record. [1]

Abstract

This profile presents Filipa Martins Alves, whose stated institutional affiliation is Unidade Local de Saúde Alto Ave in Portugal. The identified subject area is Health Sciences, a broad field that integrates clinical, biomedical, public health, and healthcare delivery research. The profile has been prepared for informational purposes in connection with the International Research Hypothesis Excellence Award. The researcher’s ORCID identifier is included as a persistent reference for identifying and exploring scholarly activities associated with the record. [1]

No publication list, bibliometric figures, specific research findings, or verified award outcome was included in the supplied details. Accordingly, the article distinguishes the information provided from broader disciplinary context and avoids attributing unverified scientific contributions to the researcher.

Keywords

Filipa Martins Alves; Health Sciences; Portugal; healthcare; clinical research; health research; healthcare services; research profile; academic recognition; International Research Hypothesis Excellence Award; ORCID.

Introduction

Health Sciences is an interdisciplinary domain encompassing the investigation of human health, illness, healthcare interventions, health systems, and factors influencing health outcomes. Research within this domain can range from laboratory and clinical studies to epidemiology, health services research, nursing, rehabilitation, and population health. The World Health Organization provides international reference material on health systems, health priorities, and evidence-informed approaches to improving health. [2]

The supplied affiliation for Filipa Martins Alves is Unidade Local de Saúde Alto Ave, Portugal. The institution name and country provide the stated organizational and geographic context for this profile. The available information does not specify a clinical specialty, academic appointment, research project, or individual scientific focus. Such details should be included only after confirmation through institutional or scholarly sources.

An academic recognition profile should distinguish verified biographical facts from disciplinary background and assessment. This distinction supports transparent presentation and helps readers evaluate the provenance and reliability of information about a researcher’s work.

Research Profile

Filipa Martins Alves is associated with Unidade Local de Saúde Alto Ave in Portugal according to the supplied profile information. Health Sciences is the designated subject area. Further details about professional role, academic qualifications, research interests, specialist practice, and institutional responsibilities were not provided and cannot be reliably inferred from the affiliation alone.

ORCID provides persistent digital identifiers for researchers and supports the association of individuals with scholarly outputs and professional activities. An ORCID identifier can help readers locate a researcher’s record, but the existence of an identifier does not independently verify every biographical detail or establish the quality of associated research. [1]

Research Contributions

The information supplied for this profile does not include specific research papers, project summaries, clinical studies, patents, datasets, or documented contributions attributable to Filipa Martins Alves. Consequently, no particular discovery, clinical innovation, or scientific finding is presented as the researcher’s established achievement.

In Health Sciences, contributions may include the generation of clinical evidence, the evaluation of healthcare interventions, improvements in patient safety, advances in diagnostic practice, research into disease prevention, or studies of health service effectiveness. The relevance of any contribution depends on the research question, methods, evidence, reproducibility, and significance of the reported findings. [3]

To develop this section further, verified publication records and project information should be reviewed. Each contribution should be linked to a specific source, with appropriate recognition of co-authors, collaborators, and the research teams involved.

Publications

No publication titles, journal names, publication years, co-author details, or DOI records were included in the supplied information. A publication list therefore cannot be reliably compiled for this article without further verification.

A complete academic bibliography should be based on authoritative publisher pages, institutional repositories, or recognized scholarly databases. Each entry should include the authors, publication year, title, journal or book, volume and issue where applicable, page range or article number, and DOI when available. A DOI should be associated only with the publication it actually identifies.

Readers may consult the researcher’s ORCID record to investigate whether scholarly works have been associated with the identifier. The completeness and accuracy of any record should be checked against the original publication and other authoritative sources. [1]

Research Impact

The research impact of Filipa Martins Alves cannot be quantified from the information currently supplied. No verified document count, citation count, h-index, clinical outcome, policy contribution, or other impact measure is available for inclusion in this profile.

Research impact in Health Sciences can be evaluated through multiple forms of evidence, including citations, methodological contributions, clinical relevance, use in guidelines, influence on health policy, improvements in service delivery, and measurable benefits to patients or communities. These forms of impact require different assessment methods and should not be assumed from institutional affiliation alone. [3]

Quantitative indicators can provide useful context, but their interpretation depends on the publication database, the time period considered, the discipline, and the completeness of the researcher’s records. Responsible research assessment combines appropriate quantitative evidence with qualitative review of the work and its documented outcomes. [4]

Award Suitability

This profile is prepared in the context of the International Research Hypothesis Excellence Award. The stated Health Sciences subject area provides a general disciplinary context for considering the researcher’s work. However, the information supplied does not establish whether Filipa Martins Alves has been nominated, shortlisted, selected, or formally recognized by the award organizer.

A transparent award assessment may consider originality, research quality, methodological rigor, relevance to the nominated discipline, publication integrity, documented outcomes, and contributions to the scientific or professional community. Bibliometric indicators may be considered where available, but they should not replace examination of the research itself. [4]

Before this profile is used as an official award announcement, the organizer should confirm the candidate’s identity, current affiliation, relevant research outputs, eligibility, and award status. Event details and applicable criteria should be checked through the official award website. [5]

Conclusion

Filipa Martins Alves is identified in the supplied information as being affiliated with Unidade Local de Saúde Alto Ave in Portugal, with Health Sciences listed as the subject area. The ORCID identifier included in the profile offers a reference for locating potentially associated scholarly information. Further details about publications, research specialization, citation metrics, and specific academic contributions have not been supplied.

A fuller and more informative academic recognition article would incorporate verified publications, research summaries, documented outcomes, and confirmed award information. Until these details are available, the profile should be understood as a preliminary informational presentation rather than an independently verified assessment of research achievements.

References

  1. ORCID. (n.d.). ORCID: Persistent digital identifiers for researchers.
    https://orcid.org/0009-0004-2813-6556
  2. World Health Organization. (n.d.). Health topics.
    https://www.who.int/health-topics
  3. National Institutes of Health. (n.d.). Research at NIH.
    https://www.nih.gov/research-training
  4. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431.
    DOI: https://doi.org/10.1038/520429a
  5. Research Hypothesis. (n.d.). Official website.
    https://researchhypothesis.com/

Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award

Dr. Kholoud Alwosaibai | Medicine and Health Sciences | Best Researcher Award | Director | King Fahad Specialist Hospital | Saudi Arabia

Dr. Kholoud Alwosaibai is a highly accomplished biomedical scientist, cancer geneticist, and immunotherapy specialist with over fifteen years of progressive experience in translational oncology, molecular medicine, and clinical genomics. She currently serves as the Director of the Biomedical Research Department at King Fahad Specialist Hospital in Dammam, Saudi Arabia, where she leads multiple funded national research programs in cancer genetics and immuno-oncology. Dr. Kholoud Alwosaibai earned her Ph.D. in Cellular and Molecular Medicine from the University of Ottawa, Canada, focusing on cancer therapeutics, and completed advanced postdoctoral training in immuno-oncology at the same institution. Her educational background also includes a Master’s degree in Medical Biotechnology and a Bachelor’s degree with honors in Biology, complemented by postgraduate certifications from the University of Manchester, Harvard Medical School, and the University of California, San Diego, in bioinformatics, cancer omics, and genomics. Professionally, Dr. Alwosaibai has held various leadership positions, including Head of the Research, Development, and Innovation Unit, Program Manager at the Saudi Genome Satellite Center, and Founder and Vice President of the DAEM Society for Oncology Research. Her research interests span cancer genetics, molecular diagnostics, CAR-T cell therapy, and CRISPR-based genome editing, with a strong focus on precision medicine and the clinical translation of genomic data. Dr. Kholoud Alwosaibai possesses an advanced skill set in next-generation sequencing, cancer variant interpretation, bioinformatics, cellular therapy development, and stem cell research, making her a recognized expert in translational and clinical biomedical research. She has published extensively in high-impact, peer-reviewed journals indexed in Scopus, PubMed, and Web of Science, contributing to global advancements in cancer biology and immunotherapy. Her collaborative work has been featured in leading journals such as Scientific Reports, BMC Cancer, Experimental and Therapeutic Medicine, and Oncotarget. Among her notable recognitions are national research grant awards from the Saudi National Institutes of Health and Sanad Society, as well as an award of excellence from the Saudi Arabian Cultural Bureau in Canada for her outstanding doctoral research performance. Throughout her career, Dr. Kholoud Alwosaibai has demonstrated a strong commitment to mentorship, scientific integrity, and capacity building in Saudi Arabia’s biomedical research landscape. Her visionary leadership, innovative research initiatives, and dedication to developing genomic medicine infrastructure position her as an influential figure in advancing cancer research and personalized therapeutics. In conclusion, Dr. Kholoud Alwosaibai’s professional journey reflects a rare blend of scientific excellence, leadership, and global collaboration, making her an inspiring model for emerging scientists and a driving force for the future of precision oncology and genomic innovation.

Profile: Scopus | ORCID

Featured Publications 

  1. Alwosaibai, K., Abedini, A., Al-Hujaily, E. M., Tang, Y., Garson, K., Collins, O., & Vanderhyden, B. C. (2017). PAX2 maintains the differentiation of oviductal epithelium and inhibits the transition to a stem cell-like state. Oncotarget. Citations: 85

  2. Gharaibeh, L., Elmadany, N., Alwosaibai, K., & Alshaer, W. (2020). Notch 1 in cancer therapy: Possible clinical implications and challenges. Molecular Pharmacology. Citations: 64

  3. Ghandorah, S., & Alwosaibai, K. (2021). Post-liver transplantation GVHD: Time to consider histocompatibility testing. Journal of Liver Transplantation. Citations: 22

  4. Alwosaibai, K., Al-Hujaily, E. M., Alamri, S., Ghandorah, S., Garson, K., & Vanderhyden, B. C. (2022). PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer. Experimental and Therapeutic Medicine, 23(6), 412. Citations: 37

  5. Alwosaibai, K., Aalmri, S., Mashhour, M., Ghandorah, S., Alshangiti, A., Azam, F., Selwi, W., Gharaibeh, L., Alatawi, Y., Alruwaii, Z., & Alsaab, H. O. (2023). PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers. BMC Cancer, 23(1), 13. Citations: 41

  6. Alessy, S. A., Almotlak, A. A., Alattas, M., Alshareef, A., Alwosaibai, K., Alghamdi, M. A., Razack, H. I. A., & Alqahtani, S. A. (2024). Cancer research challenges and potential solutions in Saudi Arabia: A qualitative discussion group study. JCO Global Oncology, 10, e2300189. Citations: 18

  7. Alwosaibai, K., Alruwaii, Z. I., Mashhour, M., Almsned, F. M., Asraf, R., Alrsheedy, W., Alessa, A., Almohanna, H., Selwi, W., & Azam, F. (2024). Dysgerminomas: Germ cell tumors exhibit high expression of PD-L1 and are associated with high TILs and good prognosis. Scientific Reports, 14(1), 24191. Citations: 12

 

Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences | Head of Department | Wroclaw Medical University | Poland

Assoc. Prof. Dr. Katarzyna Madziarska is a distinguished Polish clinician-scientist, educator, and researcher whose career has been dedicated to advancing the fields of diabetology, nephrology, and internal medicine through outstanding academic leadership, clinical practice, and research excellence. She obtained her MD and PhD from Wroclaw Medical University, where she currently serves as Head of the Clinical Department of Diabetology, Hypertension, and Internal Diseases, a position that allows her to combine patient care with cutting-edge research and medical education. Her professional experience spans decades, including roles as resident, assistant, senior assistant, adjunct, and ultimately associate professor, giving her a comprehensive understanding of clinical and academic medicine. She has been actively involved in postgraduate medical training and serves as a coordinator for trainees, a member of doctoral and habilitation committees, and a lecturer at both undergraduate and postgraduate levels. Her research interests are focused on micro- and macrovascular complications of diabetes, diabetic nephropathy, chronic kidney disease, transplantology, and the long-term health consequences of COVID-19. She has authored 112 documents, 1,076 citations, and 15 h-index, demonstrating her sustained scientific output and influence within the international medical community. Her research skills include designing and coordinating clinical trials (Phase III and IV) as a principal investigator and national coordinator, reviewing manuscripts for international journals, supervising PhD theses, and managing multi-disciplinary research projects like the COLOS study on COVID-19 outcomes. She is also experienced in translational research linking immunological, metabolic, and renal parameters to improve clinical practice. Assoc. Prof. Dr. Katarzyna Madziarska is an active member of prestigious professional bodies such as the Polish Society of Nephrology (President of the Lower Silesia Branch), Polish Society of Diabetology (Board Member), and the Polish Academy of Sciences Clinical Sciences Committee, where she contributes to advancing healthcare policy and scientific development. Her organizational contributions include serving on the Senate and Faculty Council of Medical Sciences at Wroclaw Medical University, membership in the Bioethics Committee, and participation in the Scientific Council for Clinical Trials, demonstrating her commitment to institutional governance and ethical research conduct.

Profile :  Scopus | ORCID

Featured Publications

  1. Diabetes Mellitus and Old Age – Risk Factors in Renal Replacement Therapy – 2020 – Citations: 48

  2. Evaluation of Immunological Parameters in Lipid Metabolism Disturbances in Primary Glomerulonephritis – 2019 – Citations: 35

  3. Microvascular and Macrovascular Complications in Diabetic Nephropathy: Clinical Predictors and Outcomes – 2021 – Citations: 62

  4. Post-COVID-19 Complications and Kidney Function: A Clinical Perspective – 2022 – Citations: 54

  5. Clinical Trials in Diabetes and Chronic Kidney Disease: Lessons from Multicenter Studies – 2023 – Citations: 39

  6. Role of Molecular Mechanisms in Homeostasis Regulation in Nephrology – 2020 – Citations: 42